Unsubscribe
Please enter your email address below to be removed from future emails.
Please enter your email address below to be removed from future emails.
WARNING: ABUSE, MISUSE, AND ADDICTION
QuilliChew ER has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including QuilliChew ER, can result in overdose and death. Before prescribing QuilliChew ER, assess each patient’s risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout treatment, reassess each patient’s risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.
INDICATION
QuilliChew ER® (methylphenidate HCI) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
WARNING: ABUSE, MISUSE, AND ADDICTION
QuilliChew ER has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including QuilliChew ER, can result in overdose and death. Before prescribing QuilliChew ER, assess each patient’s risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout treatment, reassess each patient’s risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.
Please see Full Prescribing Information for QuilliChew ER, including Boxed Warning regarding Abuse, Misuse, and Addiction.
You are about to leave QuilliChewERhcp.com and enter a website operated by a third party. Would like to continue?
To learn more about Tris ADHD products, or to speak to a representative, please click below.
Request Info